5 Health Related Initiatives That Might Transform The World In The Future

Hello everyone, and welcome to my blog today where I will tell you about 5 health related projects that have the potential to change the world in the future

Some of these projects are still in the testing phase, while others have been finished 2020 pushed healthcare to greater heights, with health entrepreneurs playing a vital part in shaping this new environment; virtual care delivery has been extensively accepted, digitalization efforts have advanced, and the FDA authorized the first software-only treatment. While COVID-19 vaccinations are now available.


I believe that with these pandemics occurring, scientists accelerate their research and new breakthroughs occur, and you should not be shocked if you see a cure for cancer cells in the next ten years.

Here are 5 health related initiatives that might transform the world in the future.

5) Aleph Farms

Aleph Farms was founded in 2017 by Dr. Didier Toubia and Professor Shulamit Levenberg of the Biomedical Engineering Faculty at the Technion.

Aleph Farms debuted the world's first slaughter-free steak produced from cow cells in 2018, as well as a cultivated rib-eye steak earlier this year. In January, the business signed an arrangement with the Food Industry Group of Japanese multinational Mitsubishi Corporation to deliver cultivated meat to Japan, followed by a partnership to operate in Brazil.

 You can read more about it here

4) BenchSci

BenchSci’s marquee offering — an antibody selection service — employs machine learning to select antibodies in as little as 30 seconds (versus the 12 weeks antibody selection typically takes). The company claims it reduces consumable costs by up to $3 million per year by cutting down on inappropriate antibodies, with features that support search by protein targets and filtering by technique and 16 other experimental variables (including organism, tissue, cell type, and disease).

You can read more about it here


3) Flatiron

Flatiron Health is utilising data and analytics to combat cancer, which it believes cannot be “solved” solely by the healthcare community, as well as by the technology industry. As a result, since Flatiron's inception in 2012, It has expanded to over 500 people with expertise in healthcare and technology, including employees from Google and Amazon, cancer centres varying from Memorial Sloan-Kettering to rural private practises, academia, biopharma businesses, charities, and governmental entities.

You can read more about it here


2) Lu-PSMA-617 Concept Drug

A new class of medication successfully targets treatment-resistant prostate cancer and extends patients' lives. A phase 3 trial presented at the European Association of Urology conference revealed that the therapy delivers beta radiation directly to tumour cells, is well tolerated by patients, and keeps them alive for longer than usual care.

Many patients with advanced prostate cancer and their families can benefit from Lu-PSMA-617." According to Professor Johann de Bono: "Our findings indicate that this potent radioactive medication may accurately deliver radiation to cancer cells and kill them, therefore extending patients' lives.

You can read more about it here



1) Trojan Horse Drug

A “Trojan Horse” drug that can kill cancer and bacterial cells without damaging nearby healthy tissue has been successfully tested by scientists.

Scientists at the University of Edinburgh combined the tiny cancer-killing molecule SeNBD with a chemical food ingredient to mislead malignant cells into consuming it.

The peer-reviewed experimental study was conducted on zebrafish and human cells, but experts believe additional research is needed to clarify whether it is a safe and effective means of treating early-stage cancer and drug-resistant bacteria.

Cancerous cells are “greedy” and need to consume high amounts of food for energy and they typically ingest more than healthy cells, said the University of Edinburgh. By coupling SeNBD with a chemical food compound it becomes the “ideal prey for harmful cells” which ingest it “without being alerted to its toxic nature”. The drug was invented by University of Edinburgh researchers who compared it to a Trojan Horse, and its effects to a “metabolic warhead”. SeNBD is also a light-activated photosensitizer, meaning it kills cells only after it is turned on by visible light.

According to the institution, this implies that a surgeon can precisely determine when to activate the medication, decreasing the risks of it damaging healthy tissues and avoiding adverse effects like hair loss experienced by other anti-cancer drugs.

These drug inventions and further medical research would change our world and have the potential to eliminate major illnesses such as cancer.

The previous year taught us how important these ideas are from a health standpoint, and we wish all of these health startups success with their discoveries.

You can read more about it here

These were the 5 new medical innovations. I hope you enjoyed the information.

Comments